Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Three Amigos Stock Thread -- Ignore unavailable to you. Want to Upgrade?

To: Tummus1 who wrote (4245)	5/3/1998 6:52:00 PM
From: LTK007	Read Replies (1) \| Respond to of 29382

TWEST,this was just the opening headlining story on CBS national news tonight.But they did not name Entremed specifically,but had a brief voice segment from Folkman.The National Institute said they are going to move to fast track Angiostatin,but are still a year away from test on humans,as they gave the usual caution that dramatic cancer starving success with mice does not gurantee the same success with humans. I have been following this for 6-months now,and to be honest I consider the Folkman work to be the most exciting thing going on in the world today regards actually finding a cure for cancer--Folkman himself is a brilliant scientist,and his name maybe as famous as Salk someday.BTW,I do not own any stock in ENMD. The last time there was news for ENMD the stock ran up from about 11 to 17 in one day,but then fell back since,when people realized how long the wait.But this should have a big run tomorrow,and perhaps more lasting this time as the National Institute of Cancer in behind this--this is a VERY Interesting company--max90

To: Tummus1 who wrote (4245)	5/3/1998 11:36:00 PM
From: Sergio H	Read Replies (2) \| Respond to of 29382

TWEST, thanks for bringing up ENMD. It's definatly going to get some attention tomorrow. It will be fun to watch. Sergio